The single most important piece of infrastructure we built was the welcome series.

Most welcome series are three emails and a discount code. Pharmacopia's needed to do something harder: take someone who recognized the brand from a hotel stay and convert them into a direct customer. That's not a job for generic "here's 10% off" messaging.

We built a welcome series that led with the brand story. Hotel-to-home positioning. The "luxury you already trust, now available for your bathroom" angle. Natural formulations with aromatherapeutic credentials. The kind of content that earns the purchase instead of discounting it.

The result was a welcome series that generated $53,635 in flow revenue—70.9% of all flow revenue—at a 35% conversion rate. Email 1 alone drove $50,797 at a $27.21 revenue per recipient. For context, a good RPR for email campaigns is $0.10-0.30. The welcome series was running at nearly 100x that.

Pharmacopia's list included first-time browsers, single-purchase customers, loyal repeat buyers, and lapsed customers from years past. Sending them all the same campaigns was leaving significant revenue unrealized.

We built engagement-based segments across three time windows—30, 120, and 180 days—alongside purchase-based tiers: VIP customers, one-time buyers, two-time buyers, and three-time buyers. We layered in product interest segments for their hero collections: Verbena, Citrus, and Argan Oil.

The impact of this segmentation showed most dramatically during BFCM. VIP-first access to the Black Friday sale generated $2,600 at a $1.23 RPR—nearly 20x the revenue per recipient of the broad Black Friday blast sent the following day. Same offer. Same product. Different audience, dramatically different results.

Black Friday for a natural luxury skincare brand isn't just a promotional window—it's the most important revenue moment of the year. We built for it accordingly.

The BFCM offer structure—30% off sitewide plus free gift choice on $100+ orders—was designed to increase AOV while rewarding purchase intent. We deployed 12 campaigns across the BFCM window with 3-4 hour intervals between sends during peak days, ensuring maximum visibility without training customers to ignore emails.

The sequencing mattered. VIP access 24-48 hours before the general announcement. Segmented sends by engagement tier. BFCM-specific flow variants on welcome, cart, and checkout to capture the high-traffic period.

Total BFCM email revenue: $18,795. Email attribution during the window: 50%+. More than paid ads. More than any other channel.

Running multiple campaigns during BFCM week without killing deliverability requires infrastructure most brands don't build until after they've hurt themselves.

We suppressed 20,000 bot profiles before peak season began. Fifteen suppression segments filtered hard bounces, unengaged profiles, spam markers, and fake addresses. The 40,000 active profiles left were the ones who actually wanted to hear from Pharmacopia.

The result: a 50.4% weighted average open rate across Q3/Q4 campaigns. When you're only sending to people who want your emails, your emails perform.

Email became the #1 revenue channel for Pharmacopia during Q4 2025, accounting for 53% of all store revenue. Email attribution grew from ~48% in Q3 to 53% in Q4—a 5 percentage point increase in the most competitive quarter of the year.

• Email revenue: +69% YoY
• Flow conversions: +288% YoY (3.9x multiplier)
• Overall Shopify store revenue: +18% YoY
• Repeat orders: +~20% YoY

• Campaign revenue: +13.3% with 17% fewer campaigns sent
• Email attribution: ~48% (Q3) → 53% (Q4)
• Flow revenue as % of total email: 58% (Q3) → 53% (Q4), reflecting the intentional shift toward campaign-driven revenue during holiday season
• Q4 campaign conversion rate: +5.5% improvement over Q3 (excluding BFCM broad sends)

• BFCM week campaign revenue: 5.6x October weekly average
• BFCM conversions: 7x October weekly average
• Send velocity: 10 campaigns in 8 days (3.3x normal pace)
• Pop-up conversion rate during BFCM: ~8%
• BFCM flows activated: 6 dedicated seasonal variants

• Welcome Series conversion rate: 35% (maintained Q3 → Q4)
• Welcome Series Email 1 open rate: 88.9% (Q3) → 87.2% (Q4) — stable
• Welcome Series as % of flow revenue: 75.7% (Q3) → 70.5% (Q4)
• BFCM-specific flows: contributed ~10% of Q4 flow revenue

• Active profiles after bot suppression: ~40,000 (from ~66,000 total)
• Engaged segment click rate: 41% (vs ~10% industry average)
• Open rate (excluding BFCM broad sends): 55-58% throughout partnership
• Educational content open rates: 70-82%
• Repeat orders: +~20% YoY

Pharmacopia proves that brand equity and email performance are two different things—and you need both.

The brand had everything: hotel credibility, genuine natural formulations, a compelling founder story. What it didn't have was infrastructure that translated that equity into direct revenue. No VIP strategy. No peak-season execution plan. No welcome series that actually converted.

The breakthrough wasn't a single campaign or a clever subject line. It was building the foundation: a welcome series converting at 35%, segmentation that knew the difference between a first-time browser and a loyal VIP, and a BFCM execution plan that treated the most important revenue window of the year accordingly.

When you have a brand that resonates—hotel guests who love the product, customers who appreciate the natural formulations, gift-buyers looking for something premium—your email job isn't to chase them with discounts. It's to give them a clear, compelling path from recognition to purchase.

By Q4 2025, email wasn't just a marketing channel for Pharmacopia. It was their business.